Data gathered: October 8
Alternative Data for DaVita
Alternative Data | Value | 3m Change | Trend | Benchmark | |
---|---|---|---|---|---|
Job Posts | 3,000 | Sign up | Sign up | Sign up | |
Sentiment | 95 | Sign up | Sign up | Sign up | |
Webpage traffic | 1,061,000 | Sign up | Sign up | Sign up | |
Employee Rating | 66 | Sign up | Sign up | Sign up | |
Google Trends | N/A | Sign up | Sign up | Sign up | |
Patents | N/A | Sign up | Sign up | Sign up | |
4chan Mentions | N/A | Sign up | Sign up | Sign up | |
Facebook Engagement | 1,468 | Sign up | Sign up | Sign up | |
Facebook Followers | 124,384 | Sign up | Sign up | Sign up | |
Instagram Followers | 24,735 | Sign up | Sign up | Sign up | |
Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Mentions | 9 | Sign up | Sign up | Sign up | |
Stocktwits Subscribers | 2,201 | Sign up | Sign up | Sign up | |
Twitter Followers | 14,594 | Sign up | Sign up | Sign up | |
Twitter Mentions | N/A | Sign up | Sign up | Sign up | |
X Mentions | 3 | Sign up | Sign up | Sign up | |
Youtube Subscribers | 46,100 | Sign up | Sign up | Sign up | |
News Mentions | N/A | Sign up | Sign up | Sign up | |
Customer reviews | N/A | Sign up | Sign up | Sign up | |
Business Outlook | 52 | Sign up | Sign up | Sign up | |
Linkedin Employees | 38,366 | Sign up | Sign up | Sign up |
About DaVita
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

Price | $127.71 |
Target Price | Sign up |
Volume | 305,210 |
Market Cap | $9.16B |
Year Range | $127.69 - $177.35 |
Dividend Yield | 0% |
PE Ratio | 12.62 |
Analyst Rating | 0% buy |
Industry | Medical Care Facilities |
In the news
![]() |
DaVita (DVA) Valuation: Is the Recent Pullback an Opportunity for Investors?October 6 - Yahoo |
![]() |
DaVita HealthCare (DVA) Stock Slides as Market Rises: Facts to Know Before You TradeOctober 6 - Yahoo |
![]() |
Robeco Institutional Asset Management B.V. Buys 37,156 Shares of DaVita Inc. $DVAOctober 6 - ETF Daily News |
![]() |
Brokerages Set DaVita Inc. (NYSE:DVA) Price Target at $158.00October 5 - ETF Daily News |
![]() |
DaVita HealthCare (DVA) is a Top-Ranked Growth Stock: Should You Buy?October 2 - Yahoo |
![]() |
V Square Quantitative Management LLC Acquires 449 Shares of DaVita Inc. $DVAOctober 2 - ETF Daily News |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q2 '25 | 3.38B | 2.44B | 943M | 199M | 688M | 2.950 |
Q1 '25 | 3.22B | 2.24B | 984M | 163M | 598M | 2.000 |
Q4 '24 | 3.29B | 2.23B | 1.07B | 259M | 727M | 2.240 |
Q3 '24 | 3.26B | 2.15B | 1.11B | 215M | 695M | 2.500 |
Q2 '24 | 3.19B | 2.14B | 1.04B | 223M | 645M | 2.500 |
Insider Transactions View All
BUFFETT WARREN E filed to sell 32,160,579 shares at $140.6. August 4 '25 |
HEARTY JAMES O filed to sell 26,038 shares at $150. July 24 '25 |
BUFFETT WARREN E filed to sell 33,796,541 shares at $140.2. May 27 '25 |
BUFFETT WARREN E filed to sell 33,880,485 shares at $138.6. May 27 '25 |
BUFFETT WARREN E filed to sell 33,808,519 shares at $139.6. May 27 '25 |
Similar companies
Congress Trading View All
Politician | Filing Date | Type | Size |
---|---|---|---|
Gerald Moran Republican |
Jan 17, 24 | Sell | $1K - $15K |
Gerald Moran Republican |
Jan 17, 24 | Sell | $1K - $15K |
Thomas Tuberville Republican |
Jan 12, 24 | Sell | $1K - $15K |
Read more about DaVita (DVA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of DaVita?
The Market Cap of DaVita is $9.16B.
What is DaVita's PE Ratio?
As of today, DaVita's PE (Price to Earnings) ratio is 12.62.
What is the current stock price of DaVita?
Currently, the price of one share of DaVita stock is $127.71.
How can I analyze the DVA stock price chart for investment decisions?
The DVA stock price chart above provides a comprehensive visual representation of DaVita's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling DaVita shares. Our platform offers an up-to-date DVA stock price chart, along with technical data analysis and alternative data insights.
Does DVA offer dividends to its shareholders?
As of our latest update, DaVita (DVA) does not offer dividends to its shareholders. Investors interested in DaVita should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of DaVita?
Some of the similar stocks of DaVita are Encompass Health, Brookdale Senior Living, Amedisys, Tenet Healthcare, and Nutex Health.
.